Next Article in Journal
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease
Next Article in Special Issue
Targeted Secretion Inhibitors—Innovative Protein Therapeutics
Previous Article in Journal
Genetics of Dothistromin Biosynthesis in the Peanut Pathogen Passalora arachidicola
Previous Article in Special Issue
Ribosome-Inactivating Proteins: From Plant Defense to Tumor Attack

Novel Cytotoxic Vectors Based on Adeno-Associated Virus

Hubertus Wald Cancer Center, Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Toxins 2010, 2(12), 2754-2768;
Received: 11 November 2010 / Revised: 29 November 2010 / Accepted: 30 November 2010 / Published: 1 December 2010
(This article belongs to the Special Issue Toxins as Therapeutics)
Vectors based on adeno-associated virus (AAV) are promising tools for gene therapy. The production of strongly toxic vectors, for example for cancer-directed gene transfer, is often unfeasible due to uncontrolled expression of toxic genes in vector-producing cells. Using an approach based on transcriptional repression, we have created novel AAV vectors carrying the genes coding for diphtheria toxin A (DTA) and the pro-apoptotic PUMA protein. The DTA vector had a significant toxic effect on a panel of tumor cell lines, and abrogation of protein synthesis could be shown. The PUMA vector had a toxic effect on HeLa and RPMI 8226 cells, and sensitized transduced cells to doxorubicin. To permit targeted gene transfer, we incorporated the DTA gene into a genetically modified AAV-2 capsid previously developed by our group that mediates enhanced transduction of murine breast cancer cells in vitro. This vector had a stronger cytotoxic effect on breast cancer cells than DTA vectors with wildtype AAV capsid or vectors with a random capsid modification. The vector production and application system presented here allows for easy exchange of promotors, transgenes and capsid specificity for certain target cells. It will therefore be of great possible value in a broad range of applications in cytotoxic gene therapy and significantly broadens the spectrum of available tools for AAV-based gene therapy. View Full-Text
Keywords: adeno-associated virus; cytotoxic gene therapy; vector targeting adeno-associated virus; cytotoxic gene therapy; vector targeting
Show Figures

Figure 1

MDPI and ACS Style

Kohlschütter, J.; Michelfelder, S.; Trepel, M. Novel Cytotoxic Vectors Based on Adeno-Associated Virus. Toxins 2010, 2, 2754-2768.

AMA Style

Kohlschütter J, Michelfelder S, Trepel M. Novel Cytotoxic Vectors Based on Adeno-Associated Virus. Toxins. 2010; 2(12):2754-2768.

Chicago/Turabian Style

Kohlschütter, Johannes, Stefan Michelfelder, and Martin Trepel. 2010. "Novel Cytotoxic Vectors Based on Adeno-Associated Virus" Toxins 2, no. 12: 2754-2768.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop